Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

m 6 A RNA methylation: from mechanisms to therapeutic potential
P. Cody He, Chuan He
The EMBO Journal (2021) Vol. 40, Iss. 3
Open Access | Times Cited: 464

Showing 1-25 of 464 citing articles:

RNA modifications detection by comparative Nanopore direct RNA sequencing
Adrien Léger, Paulo Amaral, Luca Pandolfini, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 274
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 239
RNA m6A methylation across the transcriptome
Erdem Sendinc, Yang Shi
Molecular Cell (2023) Vol. 83, Iss. 3, pp. 428-441
Open Access | Times Cited: 184
RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 167
The plasticity of mRNA translation during cancer progression and therapy resistance
Lucilla Fabbri, Alina Chakraborty, Caroline Robert, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 9, pp. 558-577
Closed Access | Times Cited: 162
Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 137
RNA polymerase II speed: a key player in controlling and adapting transcriptome composition
Lisa Muniz, Estelle Nicolas, Didier Trouche
The EMBO Journal (2021) Vol. 40, Iss. 15
Open Access | Times Cited: 134
Exon architecture controls mRNA m 6 A suppression and gene expression
P. Cody He, Jiangbo Wei, Xiaoyang Dou, et al.
Science (2023) Vol. 379, Iss. 6633, pp. 677-682
Open Access | Times Cited: 129
Methylation multiplicity and its clinical values in cancer
Xiaofeng Dai, Tiejun Ren, Yuxin Zhang, et al.
Expert Reviews in Molecular Medicine (2021) Vol. 23
Open Access | Times Cited: 98
Transcriptome-wide profiling and quantification of N6-methyladenosine by enzyme-assisted adenosine deamination
Yu‐Lan Xiao, Shun Liu, Ruiqi Ge, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 7, pp. 993-1003
Open Access | Times Cited: 98
METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis
Xueju Wei, Yue Huo, Jingnan Pi, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 8, pp. 1278-1290
Closed Access | Times Cited: 97
Excess body weight: Novel insights into its roles in obesity comorbidities
Xiang Zhang, Suki Ha, Harry Cheuk-Hay Lau, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 16-27
Open Access | Times Cited: 96
Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Kailin Yang, Ahmed Halima, Timothy A. Chan
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 604-623
Closed Access | Times Cited: 85
Exon junction complex shapes the m6A epitranscriptome
Xin Yang, Robinson Triboulet, Qi Liu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
Protein synthesis control in cancer: selectivity and therapeutic targeting
Joanna Kovalski, Duygu Kuzuoğlu‐Öztürk, Davide Ruggero
The EMBO Journal (2022) Vol. 41, Iss. 8
Open Access | Times Cited: 69
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 69
Cryo-EM structures of human m6A writer complexes
Shichen Su, Shanshan Li, Ting Deng, et al.
Cell Research (2022) Vol. 32, Iss. 11, pp. 982-994
Open Access | Times Cited: 68
mRNA Regulation by RNA Modifications
Wendy V. Gilbert, Sigrid Nachtergaele
Annual Review of Biochemistry (2023) Vol. 92, Iss. 1, pp. 175-198
Open Access | Times Cited: 67
RNA modification: mechanisms and therapeutic targets
Lei Qiu, Jing Qian, Yanbo Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 53
N6-methyladenosine-mediated gene regulation and therapeutic implications
Yujiao Liu, Dan Yang, Tao Liu, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 6, pp. 454-467
Closed Access | Times Cited: 51
Radiotherapy and immunology
Liangliang Wang, Connor Lynch, Sean P. Pitroda, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 7
Open Access | Times Cited: 13
Benchmarking of computational methods for m6A profiling with Nanopore direct RNA sequencing
Simone Maestri, Mattia Furlan, Logan Mulroney, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 2
Open Access | Times Cited: 12
RNA methyltransferase METTL16: Targets and function
Emily Satterwhite, Kyle D. Mansfield
Wiley Interdisciplinary Reviews - RNA (2021) Vol. 13, Iss. 2
Open Access | Times Cited: 83
N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1
Guo Dong, Jiangbo Yu, Gaojun Shan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top